Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next

A. Angelidi, Matthew J. Belanger, C. Mantzoros

Metabolism, 2020

No abstract available Keywords: COVID-19; Diabetes; Evidence-based practice; Renin-angiotensin system; Risk; SARS-CoV-2; Therapy.

Cited by 24 publications.

Field of study: Medicine

10.1016/j.metabol.2020.154245